Phosphodiesterase inhibitors for the treatment of erectile dysfunction.

Andrea Küthe, Francesco Montorsi, Karl Erik Andersson, Christian G. Stief

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The key event in penile erection is relaxation of the cavernous smooth muscle. As phosphodiesterases (PDEs) are key enzymes of the signaling pathway, knowledge about cavernous PDEs is of major importance in understanding the effects and side-effect profile of new and selective pharmacological agents for erectile dysfunction. Experimental studies revealed that gene transcripts of 14 different PDE isoenzymes are present in human cavernous tissue. Of these, PDE3 and 5 have the most prominent functional role. The effects and side effects of clinically available PDE5 inhibitors can be explained both by the distribution pattern of these two isoenzymes in various tissues, by direct inhibition of PDE5 and indirect inhibition of PDE3 in various tissues, and by the putative selectivity for a cavernous-specific PDE splice variant.

Original languageEnglish
Pages (from-to)1489-1495
Number of pages7
JournalCurrent Opinion in Investigational Drugs
Volume3
Issue number10
Publication statusPublished - Oct 2002

Fingerprint

Phosphodiesterase Inhibitors
Phosphoric Diester Hydrolases
Erectile Dysfunction
Isoenzymes
Penile Erection
Phosphodiesterase 5 Inhibitors
Smooth Muscle
Pharmacology
Enzymes
Genes
Inhibition (Psychology)

ASJC Scopus subject areas

  • Pharmacology

Cite this

Phosphodiesterase inhibitors for the treatment of erectile dysfunction. / Küthe, Andrea; Montorsi, Francesco; Andersson, Karl Erik; Stief, Christian G.

In: Current Opinion in Investigational Drugs, Vol. 3, No. 10, 10.2002, p. 1489-1495.

Research output: Contribution to journalArticle

Küthe, Andrea ; Montorsi, Francesco ; Andersson, Karl Erik ; Stief, Christian G. / Phosphodiesterase inhibitors for the treatment of erectile dysfunction. In: Current Opinion in Investigational Drugs. 2002 ; Vol. 3, No. 10. pp. 1489-1495.
@article{dbac038984004ca49773b4c8e254bdb0,
title = "Phosphodiesterase inhibitors for the treatment of erectile dysfunction.",
abstract = "The key event in penile erection is relaxation of the cavernous smooth muscle. As phosphodiesterases (PDEs) are key enzymes of the signaling pathway, knowledge about cavernous PDEs is of major importance in understanding the effects and side-effect profile of new and selective pharmacological agents for erectile dysfunction. Experimental studies revealed that gene transcripts of 14 different PDE isoenzymes are present in human cavernous tissue. Of these, PDE3 and 5 have the most prominent functional role. The effects and side effects of clinically available PDE5 inhibitors can be explained both by the distribution pattern of these two isoenzymes in various tissues, by direct inhibition of PDE5 and indirect inhibition of PDE3 in various tissues, and by the putative selectivity for a cavernous-specific PDE splice variant.",
author = "Andrea K{\"u}the and Francesco Montorsi and Andersson, {Karl Erik} and Stief, {Christian G.}",
year = "2002",
month = "10",
language = "English",
volume = "3",
pages = "1489--1495",
journal = "Current Opinion in Investigational Drugs",
issn = "1472-4472",
publisher = "Current Drugs Ltd.",
number = "10",

}

TY - JOUR

T1 - Phosphodiesterase inhibitors for the treatment of erectile dysfunction.

AU - Küthe, Andrea

AU - Montorsi, Francesco

AU - Andersson, Karl Erik

AU - Stief, Christian G.

PY - 2002/10

Y1 - 2002/10

N2 - The key event in penile erection is relaxation of the cavernous smooth muscle. As phosphodiesterases (PDEs) are key enzymes of the signaling pathway, knowledge about cavernous PDEs is of major importance in understanding the effects and side-effect profile of new and selective pharmacological agents for erectile dysfunction. Experimental studies revealed that gene transcripts of 14 different PDE isoenzymes are present in human cavernous tissue. Of these, PDE3 and 5 have the most prominent functional role. The effects and side effects of clinically available PDE5 inhibitors can be explained both by the distribution pattern of these two isoenzymes in various tissues, by direct inhibition of PDE5 and indirect inhibition of PDE3 in various tissues, and by the putative selectivity for a cavernous-specific PDE splice variant.

AB - The key event in penile erection is relaxation of the cavernous smooth muscle. As phosphodiesterases (PDEs) are key enzymes of the signaling pathway, knowledge about cavernous PDEs is of major importance in understanding the effects and side-effect profile of new and selective pharmacological agents for erectile dysfunction. Experimental studies revealed that gene transcripts of 14 different PDE isoenzymes are present in human cavernous tissue. Of these, PDE3 and 5 have the most prominent functional role. The effects and side effects of clinically available PDE5 inhibitors can be explained both by the distribution pattern of these two isoenzymes in various tissues, by direct inhibition of PDE5 and indirect inhibition of PDE3 in various tissues, and by the putative selectivity for a cavernous-specific PDE splice variant.

UR - http://www.scopus.com/inward/record.url?scp=0036780074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036780074&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 1489

EP - 1495

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1472-4472

IS - 10

ER -